<DOC>
	<DOC>NCT00770016</DOC>
	<brief_summary>The aim of this study is to further characterize the treatment related changes in insulin sensitivity, substrate metabolism and intra hepatic- and intramyocellular lipid content in patients with hypothyroidism</brief_summary>
	<brief_title>Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>written informed consent must be of legal age and competent Age &gt; 18 years presently diagnosed with hypothyroidism alcohol consumption &gt;21 units per week Malignant disease pregnancy magnetic implants or material in the body BMI &gt; 30 Heart disease (NYHA &gt;2) Uncontrolled hypertension Manifest diabetes mellitus Changes in medication, with any influence on glucose metabolism, 2 months prior to and until the end of the trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>insulin sensitivity</keyword>
	<keyword>Substrate metabolism</keyword>
	<keyword>Fatty liver</keyword>
	<keyword>intramyocellular lipid</keyword>
	<keyword>intracellular signaling</keyword>
</DOC>